Latest NmVac4-A/C/Y/W-135 Stories
World Meningitis Day is April 25, 2009 BALTIMORE, April 20 /PRNewswire/ -- The first annual World Meningitis Day begins April 25, 2009 and is gaining national support. The day is meant to raise awareness and educate Americans about the dangers of contracting the Meningococcal disease.
National Meningitis Association Urges Parents to Protect Their Preteens and Teens through Vaccination MARIETTA, Ga., Jan.
British researchers, reporting success with malaria vaccine trials, are calling for the next phase of development -- a broader vaccination base. Experts from the London School of Hygiene and Tropical Medicine said the trial has proven successful among infants and toddlers in Tanzania and Kenya, the school reported in a news release.
One-fifth of the standard dose of a commonly used meningitis vaccine may be as effective as using the full dose, researchers in Norway said. Researchers at the Norwegian Institute of Public Health and colleagues at Epicentre -- the research arm of Doctors Without Borders/Medecins Sans Frontieres -- and Mbarara University of Science and Technology in Uganda said the finding should allow scarce vaccine resources to be stretched further, especially during epidemics in Africa. In 2004, a...
Newly Published Call to Action Highlights Need to Reduce Disparities in Meningococcal Vaccination; Increase Educational Efforts BETHESDA, Md., Dec. 2 /PRNewswire/ -- The National Foundation for Infectious Diseases' (NFID) S.T.O.P. (Share. Teach. Outreach.
One fifth of the standard dose of a commonly used meningitis vaccine may be as effective as using the full dose. This new finding should allow scarce vaccine resources to be stretched further, especially during epidemics in Africa.In a study initiated by the Norwegian Institute of Public Health, together with Epicentre (the research arm of Doctors Without Borders/M©decins Sans Frontires), and Mbarara University of Science and Technology in Uganda, immune responses in patients receiving...
Infants, adolescents and young adults are at the highest risk of contracting meningococcal meningitis. Recognizing the symptoms and learning about vaccine prevention can save your child from its terrible consequences.
New Phase III data for Menveo(R) (MenACWY-CRM) show that the vaccine produced a greater immune response against meningococcal serogroups A, C, W-135 and Y in adolescents 11-18 years of age compared to Menactra(R).
A vaccine against meningitis A will be tested and if all goes well could be available in the next few years in Africa where the disease kills thousands of people each year, researchers said on Wednesday.
NEW YORK (Reuters Health) - In adolescents, intim
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.